Predictive factors for late normal tissue complications following radiotherapy for breast cancer

Breast Cancer Research and Treatment

Volumn 106, Issue 1, 2007, Pages 143-150

  Lilla, Carmen ^a   Ambrosone, Christine B ^b   Kropp, Silke ^a   Helmbold, Irmgard ^a   Schmezer, Peter ^a   Von Fournier, Dietrich ^c   Haase, Wulf ^d   Sautter Bihl, Marie Luise ^e   Wenz, Frederik ^f   Chang Claude, Jenny ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d St Vincentius Hospital   (Germany)

^e Department of Dermatology   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast cancer; Cosmesis; Late side effects; Radiotherapy; Smoking; Telangiectasia

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOSENSITIVITY; RISK FACTOR; SKIN TOXICITY; SMOKING; STATISTICAL SIGNIFICANCE; TELANGIECTASIA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; QUESTIONNAIRES; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SUBCUTANEOUS TISSUE; TELANGIECTASIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34848912294     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9480-9     Document Type: Article

References (44)

1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241
2. Fehlauer F, Tribius S, Alberti W, Rades D (2005) Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol 181:625-631
3. Johansson S, Svensson H, Denekamp J (2002) Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 52:1207-1219
4. Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J, Bartelink H (1994) Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30:1073-1081
5. Bowden SJ, Fernando IN, Burton A (2006) Delaying radiotherapy for the delivery of adjuvant chemotherapy in the combined modality treatment of early breast cancer: is it disadvantageous and could combined treatment be the answer? Clin Oncol (R Coll Radiol) 18:247-256
6. Dikomey E, Borgmann K, Peacock J, Jung H (2003) Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 56:1194-1200
7. Twardella D, Chang-Claude J (2002) Studies on radiosensitivity from an epidemiological point of view-overview of methods and results. Radiother Oncol 62:249-260
8. Bentzen SM, Overgaard J (1994) Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. Semin Radiat Oncol 4:68-80
9. Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2003) Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother Oncol 69:145-153
10. Cancer Therapy Evaluation Program (1998) Common Toxicity Criteria. Available at http://ctep.cancer.gov/reporting/ctc.html. National Institutes of Health
11. Seegenschmiedt MH (1998) Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives. Strahlenther Onkol 174(Suppl 3):25-29
12. Turesson I, Nyman J, Holmberg E, Oden A (1996) Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 36:1065-1075
13. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Van der HM, Van der SE, Bartelink H (1999) The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 45:677-685
14. Moody AM, Mayles WP, Bliss JM, A'Hern RP, Owen JR, Regan J, Broad B, Yarnold JR (1994) The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106-112
15. Bentzen SM, Overgaard M (1993) Early and late normal tissue injury after postmastectomy radiotherapy. Recent Results Cancer Res 130:59-78
16. Bentzen SM, Overgaard M, Thames HD (1989) Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 17:531-537
17. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Maat B, Van Limbergen E, Bartelink H (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 55:219-232
18. Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM, Mortimer JE, Myerson RJ, Radford D, Rush C (1995) Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31:753-764
19. Hazane F, Sauvaigo S, Douki T, Favier A, Beani JC (2006) Age-dependent DNA repair and cell cycle distribution of human skin fibroblasts in response to UVA irradiation. J Photochem Photobiol B 82:214-223
20. Gorbunova V, Seluanov A (2005) Making ends meet in old age: DSB repair and aging. Mech Ageing Dev 126:621-628
21. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW (2005) DNA repair, genome stability, and aging. Cell 120:497-512
22. Gatti RA (2001) The inherited basis of human radiosensitivity. Acta Oncol 40:702-711
23. Rogers PB, Plowman PN, Harris SJ, Arlett CF (2000) Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 57:143-154
24. Tutt A, Yarnold J (2006) Radiobiology of breast cancer. Clin Oncol (R Coll Radiol) 18:166-178
25. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12:1168-1174
26. De Ruyck K, Wilding CS, Van Eijkeren M, Morthier R, Tawn EJ, Thierens H (2005) Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res 164:237-244
27. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717-8725
28. Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von FD, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB (2005) Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11:4802-4809
29. Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2005) Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 1-8
30. Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, Alberti W, Dikomey E (2003) Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 69:137-144
31. Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D (2000) Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol 55:179-186
32. Bentzen SM, Overgaard M (1991) Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 20:159-165
33. Gehrig J, Hacki WH, Schulthess HK, Reinisch E, Kunz J, Stamm B (1987) [Radiation proctocolitis following gynecologic radiotherapy: an endoscopic study]. Schweiz Med Wochenschr 117:1326-1332
34. Bohler FK, Rhomberg W, Doringer W (1992) [Hypertension as risk factor for increased rate of side effects in the framework of breast carcinoma irradiation]. Strahlenther Onkol 168:344-349
35. Moore DE (2002) Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 25:345-372
36. Ferreira MA (2003) Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators Inflamm 12:259-267
37. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33:99-109
38. Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA (2001) Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50:851-855
39. Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB, Kadlubar FF (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ Mol Mutagen 39:184-192
40. Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4:233-238
41. Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733-744
42. Terhaard CH, Snippe K, Ravasz LA, van dT I, Hordijk GJ (1991) Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys 21:1179-1186
43. Rugg T, Saunders MI, Dische S (1990) Smoking and mucosal reactions to radiotherapy. Br J Radiol 63:554-556
44. Johansson S, Svensson H, Denekamp J (2000) Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 48:745-750